Change search criteria ↓

Search results

1 681 projects found matching your search criteria:

  1. 1. New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 …

    Principal investigator: dr Klaudia Kwiatkowski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 15, Panel: NZ7

  2. 2. The importance of the crosstalk between alpha-synuclein and sphingosine-1-phosphate-dependent signalling in experimental…

    Principal investigator: dr Joanna Agata Motyl

    Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

    Call: SONATINA 3, Panel: NZ4

  3. 3. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif…

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ7

  4. 4. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence …

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ7

  5. 5. Identification of the mechanism of antineoplastic activity of metformin, as an experimental approach to improve cancer t…

    Principal investigator: prof. Jerzy Aleksander Pałka

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: OPUS 13, Panel: NZ7

  6. 6. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac…

    Principal investigator: dr Magdalena Jolanta Sowa-Kućma

    Instytut Farmakologii PAN

    Call: SONATA 5, Panel: NZ7

  7. 7. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC…

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

    Call: SONATA BIS 2, Panel: NZ7

  8. 8. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice…

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ7

  9. 9. Dipeptidyl peptidase 8 and 9 (DPP8 and 9) in the regulation of macrophage functions - proteomic approach to search for t…

    Principal investigator: dr Maciej Suski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: SONATA 9, Panel: NZ2

  10. 10. Clinical efficacy of pharmacotherapy with antihistaminics and leukotriene antagonists and the therapy impact on cyclooxy…

    Principal investigator: Paulina Maria Korczyńska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 1, Panel: NZ5

  11. 11. Studies of molecularly imprinted polymers application for analysis of pharmaceuticals in biological systems

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: OPUS 10, Panel: ST4

  12. 12. Metabolic profiles in urine of prostate cancer patients.

    Principal investigator: Wiktor Dariusz Sroka

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: PRELUDIUM 4, Panel: NZ7

  13. 13. Pharmacokinetic and pharmacodynamics modeling of antidepressants in a mechanistic approach for efficient therapy.

    Principal investigator: prof. Filip Rybakowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  14. 14. Impact of sodium chloride supplementation for natriuresis, blood pressure and neurohormonal activity in Chronic Heart Fa…

    Principal investigator: Mateusz Guzik

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 23, Panel: NZ5

  15. 15. Effect of continuous renal replacement therapy with regional citrate anticoagulation on the concentrations of most commo…

    Principal investigator: Ilona Nowak-Kózka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: PRELUDIUM 8, Panel: NZ5

  16. 16. A new concept of inhibiting the progression of Alzheimer's disease based on the modification of the blood-brain barrier …

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ4

  17. 17. The role of gut microbiota in the treatment of epilepsy: experimental studies

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

    Call: OPUS 27, Panel: NZ4

  18. 18. Theranostic oxygen nanobubbles for cancer radiotherapy enhancement and perfusion imaging

    Principal investigator: dr hab. Martyna Elas

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 23, Panel: NZ4

  19. 19. New approach to the treatment of Alzheimer's disease targetingresolution of inflammation and modulation of biomechanical…

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ4

  20. 20. Metabolic reprogramming in age-dependent endothelial dysfunction and vascular stiffness; novel mechanism of inflamm-agei…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: MAESTRO 13, Panel: NZ4

  21. 21. Investigating the role of the focal adhesion kinase and its related signaling pathways in glucocorticoid- and stress-ind…

    Principal investigator: Michał Józef Wilczkowski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 20, Panel: NZ4

  22. 22. Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di…

    Principal investigator: dr Anna Aleksandra Radlicka-Borysewska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 19, Panel: NZ4

  23. 23. The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n…

    Principal investigator: prof. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ4

  24. 24. Role of angiotensin 1-12 and ACE-independent generation of Angiotensin II in peripheral endothelial dysfunction in heart…

    Principal investigator: Tasnim Mohaissen

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 15, Panel: NZ4

  25. 25. Effects of adenosine P2Y12 receptors inhibition on central and peripheral chemoreceptors' sensitivity in humans

    Principal investigator: dr Stanisław Tubek

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Nauk o Zdrowiu

    Call: PRELUDIUM 14, Panel: NZ4

  26. 26. Interdisciplinary view on activity of coumarins on the central nervous system - behavioral, analytical and mode of actio…

    Principal investigator: prof. Krystyna Katarzyna Skalicka-Woźniak

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ4

  27. 27. The influence of mitochondria-derived hydrogen sulfide (H2S) on the reprogramming of macrophages in atherosclerosis and …

    Principal investigator: dr Aneta Olga Stachowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: SONATA 13, Panel: NZ4

  28. 28. In Search for the novel therapeutic strategies in the treatment of brain ischemia. Determination of the neuroprotective …

    Principal investigator: dr Bartosz Sebastian Pomierny

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ4

  29. 29. Influence of selected forms of graphene nanoparticle on isolated working hypertensive heart ex-vivo

    Principal investigator: prof. Marek Witold Radomski

    Kardio-Med Silesia Sp. z o.o.

    Call: OPUS 10, Panel: NZ4

  30. 30. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto…

    Principal investigator: dr Magdalena Joanna Zaniewska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ4

  31. 31. Pharmacotherapeutic mechanisms, spectroscopic signatures, and nanomechanics of dysfunctional endothelium in liver steato…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET); Pracownia Farmakologii Doświadczalnej Śródbłonka

    Call: SYMFONIA 3, Panel: NZ4

  32. 32. Analysis of changes in reward system activity during unpredictable stress in a model of less and more anxious animals - …

    Principal investigator: dr hab. Małgorzata Helena Lehner

    Instytut Psychiatrii i Neurologii

    Call: OPUS 8, Panel: NZ4

  33. 33. Pessimism as cognitive biomarker of depression in animal model

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ4

  34. 34. Influence of the chemical structure of coumarins derivatives on their central effects evaluated in behavioral and bichem…

    Principal investigator: dr Barbara Budzyńska

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: OPUS 7, Panel: NZ4

  35. 35. Immunological biomarkers of drug resistant epilepsy and response to immunomodulatory therapy with ACTH in children

    Principal investigator: Magdalena Dorota Kaczorowska-Frontczak

    INSTYTUT - POMNIK - CENTRUM ZDROWIA DZIECKA

    Call: PRELUDIUM 6, Panel: NZ4

  36. 36. Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi…

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii PAN

    Call: HARMONIA 5, Panel: NZ4

  37. 37. The renin- angiotensin system in the breast cancer- in vitro study on metabolism and function of Angiotensin-(1-12).

    Principal investigator: dr Beata Agnieszka Bujak-Giżycka

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 5, Panel: NZ4

  38. 38. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d…

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ4

  39. 39. Studies on the mechanism regulating expression of hormone-dependent cytochromes P450 in the rat liver under conditions o…

    Principal investigator: Rafał Andrzej Skowronek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

    Call: PRELUDIUM 4, Panel: NZ4

  40. 40. The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

    Principal investigator: dr Ewelina Bator

    Instytut Farmakologii PAN

    Call: PRELUDIUM 4, Panel: NZ4

  41. 41. Analysis of the anti-nociceptive and anti-inflammatory action of histamine H4 receptor antagonist in inflammatory nocice…

    Principal investigator: Przemysław Rzodkiewicz

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

    Call: PRELUDIUM 2, Panel: NZ4

  42. 42. Search for biological background of diversified vulnerability to psychoactive substances in rats on the basis of ampheta…

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

    Call: OPUS 2, Panel: NZ4

  43. 43. Decoding signaling events inducing lipolysis in adipocytes during metabolic diseases

    Principal investigator: dr Grzegorz Sumara

    Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

    Call: DIOSCURI 1, Panel: NZ4

  44. 44. Microstructural and Cytokine Profile Evaluation of Ocular Surface Squamous Neoplasia

    Principal investigator: prof. Adam Aleksander Wylęgała

    Śląski Uniwersytet Medyczny w Katowicach

    Call: SONATA BIS 15, Panel: NZ4

  45. 45. The Effect of 8-Week Krill Oil Supplementation (2 g/day) on Musculoskeletal Pain and Complaints, Inflammatory Markers, L…

    Principal investigator: Beata Jóźwiak

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu

    Call: PRELUDIUM 24, Panel: NZ4

  46. 46. Innovative approach to support healthy ageing: a multidirectional evaluation of the health-promoting potential of iodine…

    Principal investigator: Katarzyna Karolina Krawczyk

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie

    Call: PRELUDIUM 24, Panel: NZ4

  47. 47. Iron deficiency and frailty syndrome in elderly patients with cardiovascular disease – cohort and interventional studies…

    Principal investigator: prof. Ewa Anita Jankowska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: OPUS 29, Panel: NZ4

  48. 48. Bioavaiability of doxycycline and its effect on the development of the mealworm (Tenebrio molitor)

    Principal investigator: prof. Jerzy Jan Jaroszewski

    Uniwersytet Warmińsko-Mazurski w Olsztynie

    Call: OPUS 29, Panel: NZ4

  49. 49. Determination of the molecular mechanism of BbKI peptide in regulating tissue sensitivity to insulin

    Principal investigator: Nataniel Jan Stefanowski

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM 24, Panel: NZ4

  50. 50. The role of PAQR receptors in the regulation of the corpus luteum function in cow

    Principal investigator: dr hab. Magdalena Karolina Kowalik

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

    Call: OPUS 29, Panel: NZ4

Graphic design and implementation: Jakub Piotrowski